Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Sekisui Diagnostics UK Ltd.

Download Mobile App




Focal Laser Therapy Destroys Breast Tumors

By HospiMedica International staff writers
Posted on 29 Jul 2019
A minimally invasive procedure uses laser induced heat for focal destruction of breast fibroadenomas and tumors of up to two centimeters in size.

The Novian Health (Chicago, Il, USA) Novilase Laser Therapy System consists of an 805 nanometer wavelength Laser diode source with an output of 1-8 watts, a power distribution unit with user accessible master power switch, an isolation transformer, and a thermal temperature to digital converter, all mounted in lightweight storage cart. To provide the therapy, a disposable sterile probe kit is used, consisting of a hollow stainless steel laser probe with an attached thermistor, a hollow stainless steel thermal probe with five embedded thermistors, and other accessories. The system is controlled via a computer running Windows 7 or better.

During the procedure, ultrasound or x-ray image-guidance is used to insert the two small probes into and alongside the tumor. The laser probe delivers laser energy to provide focal thermal energy, while the thermal probe monitors temperature at the edge of the desired ablation zone. Treatment times can range from 15 to 30 minutes, with the results confirmed by follow-up imaging. Studies have shown that more than 90% of malignant breast tumors are completely destroyed during one Novilase procedure, with patients reporting better health-related quality of life outcomes compared to lumpectomy.

“Novilase represents a major paradigm shift in how we treat early-stage breast cancer, effectively replacing the traditional lumpectomy. Compared to surgery, it's simply a better technique all around,” said Barbara Schwartzberg, MD, president and co-founder of Western Surgical Care (Denver, CO, USA). “Using laser technology to treat breast tumors is less invasive, less painful, and produces better cosmetic results, in addition to being significantly less expensive.”

Fibroadenoma is the most widely spread breast benign tumor, with as much as 10% of women at risk of developing it in their lifetime; it also represents more than half of breast biopsies. It affects women of all ages, but is a lot more frequent with women under 30. The pathology is often found during a medical examination or by women doing their own palpation, and radiologic images using mammography and ultrasound are used to confirm the diagnosis. In some cases, a micro biopsy is necessary to confirm its benign nature.

Related Links:
Novian Health


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
12-Channel ECG
CM1200B
Silver Member
Wireless Mobile ECG Recorder
NR-1207-3/NR-1207-E
New
Computerized Spirometer
DatospirAira
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get complete access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The new risk assessment tool determines patient-specific risks of developing unfavorable outcomes with heart failure (Photo courtesy of 123RF)

Powerful AI Risk Assessment Tool Predicts Outcomes in Heart Failure Patients

Heart failure is a serious condition where the heart cannot pump sufficient blood to meet the body's needs, leading to symptoms like fatigue, weakness, and swelling in the legs and feet, and it can ultimately... Read more

Patient Care

view channel
Image: The portable, handheld BeamClean technology inactivates pathogens on commonly touched surfaces in seconds (Photo courtesy of Freestyle Partners)

First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds

Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The Quantra Hemostasis System has received US FDA special 510(k) clearance for use with its Quantra QStat Cartridge (Photo courtesy of HemoSonics)

Critical Bleeding Management System to Help Hospitals Further Standardize Viscoelastic Testing

Surgical procedures are often accompanied by significant blood loss and the subsequent high likelihood of the need for allogeneic blood transfusions. These transfusions, while critical, are linked to various... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.